SUPPLEMENTARY TABLE 1. Search strategy to identify recombinant zoster vaccine (RZV) reports of selected pre-specified outcomes in the Vaccine Adverse Events Reporting System (VAERS) \u2014 United States, October 2017\u2013June 2018

Abstract

Supplementary table for: Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) \u2014 United States, October 2017\u2013June 2018.20192019-01-29T00:00:00Z726